Judge dismisses Intellectual Ventures claims against insurers for ineligible subject matter

A federal court in Pittsburgh, Pennsylvania ordered the dismissal of Intellectual Ventures' patent infringement action against Highmark Inc. and other health insurance companies who allegedly infringed patents related to databases on the grounds they are ineligible subject matter for patentability under the Supreme Court’s Alice decision. This case involves U.S. Patent No. 6,519,581 B1, entitled [...]

By | September 30th, 2015|Patent Investing|Comments Off on Judge dismisses Intellectual Ventures claims against insurers for ineligible subject matter

PTAB denies second Volkswagen IPR against patent owned by Marathon’s Signal IP unit

Marathon Patent Group Inc. (MARA) the patent licensing company run by CEO Doug Croxall, said that on Tuesday the Patent Trial and Appeal Board denied Volkswagen Group of America Inc.’s petition for inter partes review of a patent related to occupant restraints for vehicles. The patent at issue is U.S. Patent No. 6,012,007, “Occupant Detection [...]

By | September 30th, 2015|Patent Investing|Comments Off on PTAB denies second Volkswagen IPR against patent owned by Marathon’s Signal IP unit

(Update1) Blue Calypso raised $1.77M at 13.6% discount to yesterday’s close, shares fell 5.6%

Blue Calypso Inc. (BCYP), the patent licensing company run by CEO Andrew Levi, said it raised $1.77 million from a private placement of common stock and warrants issued to unnamed accredited investors. Dallas-based Blue Calypso said the shares were issued between September 23 and September 29, under a securities purchase agreement. The company issued 417,500 [...]

By | September 29th, 2015|Patent Investing|Comments Off on (Update1) Blue Calypso raised $1.77M at 13.6% discount to yesterday’s close, shares fell 5.6%

(Update2) Spangenberg targets Depomed’s Nucynta patent in first draft IPR petition

IP Navigation Group founder and owner Erich Spangenberg made good on his pledge to publish substantially complete petitions for inter partes review of weak drug patents today with one targeted at Depomed Inc.’s Nucynta pain medication. The draft IPR petition was published on Spangenberg’s Spangenblog under a post titled “Evergreening and Nucynta Pain Medication—Here’s How [...]

By | September 29th, 2015|Patent Investing|Comments Off on (Update2) Spangenberg targets Depomed’s Nucynta patent in first draft IPR petition

Bass and Spangenberg-led group files new IPR to invalidate Biogen MA MS drug patent

The Coalition for Affordable Drugs, the group controlled by billionaire J. Kyle Bass’ hedge fund Hayman Capital and IP Navigation Group owner Erich Spangenberg, filed another new petition for inter partes review of a patent for treating multiple sclerosis owned by Biogen MA Inc. The Sept. 28 petition cites prior art not previously considered by [...]

By | September 28th, 2015|Patent Investing|Comments Off on Bass and Spangenberg-led group files new IPR to invalidate Biogen MA MS drug patent

(Update1) Patriot Scientific plunges 64% after adverse claims construction ruling in infringement action against ZTE

Shares of Patriot Scientific Corp. (PTSC) plunged as much as 65% after a federal court in San Jose, Calif., issued a claims construction ruling in an infringement dispute between its Technology Properties Ltd. LLC unit and ZTE Corp. and others that would lead to a finding of non-infringement. Magistrate Judge Paul Grewal’s claims construction ruling [...]

By | September 28th, 2015|Patent Investing|Comments Off on (Update1) Patriot Scientific plunges 64% after adverse claims construction ruling in infringement action against ZTE

(Update1) Blue Calypso reaches settlement with Yelp with initial order of 4,000 KioSentrix beacons

Blue Calypso Inc. ( BCYP ), the patent licensing company that scrapped a $5 million to $10 million pubic offering earlier this month, said it reached a settlement of an infringement action with Yelp, in which Yelp agreed to explore the use of Blue Calypso’s KIOSentrix AC powered beacons in potential distribution to Yelp's retail [...]

By | September 28th, 2015|Patent Investing|Comments Off on (Update1) Blue Calypso reaches settlement with Yelp with initial order of 4,000 KioSentrix beacons

(Update1) Emboldened by denial of Celgene’s motion for sanctions Spangenberg launches public crusade against evergreening by drug companies

Emboldened by the Patent Trial and Appeals Board’s rejection of Celgene Corp.’s (CELG) sanctions motion for allegedly abusing the IPR process under the America Invents Act, IP Navigation Group founder Erich Spangenberg has now launched a public crusade against what he calls “evergreening" and what he says big pharma calls “lifecycle management.” Spangenberg on his [...]

By | September 26th, 2015|Patent Investing|Comments Off on (Update1) Emboldened by denial of Celgene’s motion for sanctions Spangenberg launches public crusade against evergreening by drug companies

(Update3) PTAB denies Celgene’s motion for sanctions against Bass and Spangenberg’s Coalition for Affordable Drugs

The Patent Trial and Appeals Board handed billionaire J. Kyle Bass’s Hayman Capital and IP Navigation Group founder Erich Spangenberg a hugely important victory in their effort to invalidate weak patents held by pharmaceutical giants when it rejected Celgene Corp.’s motion for sanctions because of an alleged abuse of the IPR process as laid out [...]

By | September 25th, 2015|Patent Investing|Comments Off on (Update3) PTAB denies Celgene’s motion for sanctions against Bass and Spangenberg’s Coalition for Affordable Drugs

PTAB denies institution of IPRs filed by Sophos against Finjan patents

The Patent Trial and Appeal Board denied Sophos Inc.’s petitions for inter partes review of two patents of eight patents at issue in a infringement action filed by Finjan Holdings Inc. (FNJN) against Sophos. The patents at issue in the denied petitions were U.S. Patent No. 8,677,494, entitled "Malicious Mobile Code Runtime Monitoring System and [...]

By | September 25th, 2015|Patent Investing|Comments Off on PTAB denies institution of IPRs filed by Sophos against Finjan patents